We are Lonza, a Swiss CDMO with facilities around the world, and over 35 years of biologics experience. We understand the importance of reliability and integrity in every aspect of our services.

We are excited to be attending Bio Korea, Interphex Week Tokyo and Bioplus/Interphex Korea, and our teams would love to meet with you and understand how we can help grow your biotech business.

Drug candidates in the development pipeline are increasingly innovative and complex. As your CDMO of choice, we will use our industry-leading expertise and track record and ambition to accelerate your path to the clinic or commercialization for mammalian, microbial, or bioconjugates.

Schedule a meeting at one of the upcoming events

If you would like to meet with us at one of the events, please contact us below and a member of our team will get in touch.

“We are a small company and demands on our time meant we had to delay the start of the tech transfer into the Slough facility. Lonza was accommodating and reworked the schedule twice.

This was refreshing, as we have experienced CDMOs who are unable to shift the schedule.”

Julie Trulson, Ph.D. Vice President and Head of CMC, Asher Biotherapeutics

“Lonza’s brand name is a crucial factor that is particularly valuable for smaller biotechs, it lends credibility and provides comfort to investors and regulators that high-quality antibody skills will be implemented.

Lonza helped us understand the biggest risks and how they could be managed. That openness has been invaluable.”

William B. Jones, Ph.D., Senior Vice President of Pharmaceutical Development, Corvus Pharmaceutical

Lonza can support your manufacturing needs from early development to commercialization. For more information, please visit our website.